Trial Profile
Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary) ; Diclofenac (Primary)
- Indications Basal cell cancer
- Focus Biomarker; Therapeutic Use
- 24 Apr 2013 Planned end date changed from 1 Nov 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 24 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jan 2012 Planned number of patients changed from 64 to 128 as reported by ClinicalTrials.gov.